Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'

Politics

This article is being updated.

via Breitbart January 25th 2022

  2. MixedTimes.com
  3. Politics
  4. Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'